Skip to main content
Equibles
TENX logo

TENX · Tenax Therapeutics, Inc.

Track TENX — free

Use TENX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about TENX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.78 -0.12 (-6.32%) At close · Aug 20
Market Cap
$66.80M
Shares
37.42M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.78 Open$1.86 Day$1.76–1.88 52W close$1.38–18.32 Avg vol 30d6.6M Short int2.6M · 6.8% float · 1.9d Short vol71% Last earningsNov 13, 2025 DataJan 2024–Aug 2026 Filing10-Q · Jul 31

Raw chart and full-history price indicators begin at the captured split on Jan 3, 2024; bars on opposite sides are not compared.

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Jul 31, 2026

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 14.9 · calm Equity put/call 0.52
Technical
price trend
Strong Sell
50 / 200-day cross Death cross
Price vs 200-day avg −85%
below
Price vs 50-day avg −85%
below
RSI (14) 20
oversold
MACD trend Negative
52-week position 2%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −88%
trailing
6-month return −85%
trailing
YTD return −85%
this year
Relative strength −96%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) Death cross
50d $12 › 200d $12 — 200d above 50d
Institutional flow Accumulating
+43% holders QoQ · +45 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
6.83% of float · ▲ +24.9% MoM · 1.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
114 holders — near 3-yr high, broad support
Squeeze score 48
elevated · 0–100
Fundamentals
Weak
Revenue growth −100%
Y/Y
EPS growth −17%
Y/Y
Free cash flow $-35.8M
Balance sheet $97.0M
net cash
Quant / Vol
risk profile
Very High
Volatility 121%
annualized · 1-yr
Max drawdown −92%
past year
ATR 66.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
5 · 2 · 0
50 / 200-day cross
Death cross Bearish
Price vs 200-day avg
−85% Bearish
Price vs 50-day avg
−85% Bearish
RSI (14)
20 Neutral
MACD trend
Negative Bearish
52-week position
2% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) Death cross
50d $12 › 200d $12 — 200d above 50d
Institutional flow Accumulating
+43% holders QoQ · +45 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
6.83% of float · ▲ +24.9% MoM · 1.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
114 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1 Now $2 · 2% Range high $18
vs 200-day avg -85% vs 50-day avg -85% 50-day below 200-day death cross

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TENX
Tenax Therapeutics, Inc.
this stock
$66.80M -85.4% -86.7% — 6.8%
ONC
BeOne Medicines Ltd.
 $557.05B +21.5% +22179.2% 856.5 0.1%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $136.93B +19.2% +46.2% 31.5 1.6%
REGN
Regeneron Pharmaceuticals, Inc.
 $86.39B +7.1% +20.8% 20.8 3.3%
MRNA
Moderna, Inc.
 $69.62B +352.1% +4.3% — 12.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
114
% held
87.5%
Net QoQ
+11.3M sh
Top holder
FMR LLC
Held Float
View
Held by Funds
Fund positions
32
View
Short & Settlement
Short Interest Rising
Shares short
2.6M
Days to cover
1.9d
Change
+509.9K sh
View
Short Volume
Short vol %
71%
As of
Aug 20, 2026
Short Total
View
Fails to Deliver
FTD shares
810
Value
$12.2K
As of
Jul 17, 2026
View
Off-Exchange
Off-exchange %
46.2%
Week of
Jul 13, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$0
Net income (FY)
$-52.6M
EPS diluted
$-1.34
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 10, 2026
This year
14
View
Exempt Offerings
Offering
$175.0M
Filed
Aug 23, 2024
View
Earnings & Events
Earnings Calls
Last call
Nov 13, 2025
View

Performance

Raw-price comparisons begin at the captured split on Jan 3, 2024; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
TENX -2.7% -87.8% -85.2% -87.0% -85.4%
SPY -2.0% +3.3% +11.2% +2.1% +11.8%
vs SPY -0.8% -91.2% -96.3% -89.1% -97.2%
Key facts CIK 34956 CUSIP 88032L605 13F (30d) 121 filings 116 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)